Ca(2+) influx and cAMP elevation overcame botulinum toxin A but not tetanus toxin inhibition of insulin exocytosis

Am J Physiol Cell Physiol. 2001 Sep;281(3):C740-50. doi: 10.1152/ajpcell.2001.281.3.C740.

Abstract

Previous reports showed that cleavage of vesicle-associated membrane protein-2 (VAMP-2) and synaptosomal-associated protein of 25 kDa (SNAP-25) by clostridial neurotoxins in permeabilized insulin-secreting beta-cells inhibited Ca(2+)-evoked insulin secretion. In these reports, the soluble N-ethylmaleimide-sensitive factor attachment protein target receptor proteins might have formed complexes, which preclude full accessibility of the putative sites for neurotoxin cleavage. In this work, VAMP-2 and SNAP-25 were effectively cleaved before they formed toxin-insensitive complexes by transient transfection of insulinoma HIT or INS-1 cells with tetanus toxin (TeTx) or botulinum neurotoxin A (BoNT/A), as shown by immunoblotting and immunofluorescence microscopy. This resulted in an inhibition of Ca(2+) (glucose or KCl)-evoked insulin release proportionate to the transfection efficiency (40-50%) and an accumulation of insulin granules. With the use of patch-clamp capacitance measurements, Ca(2+)-evoked exocytosis by membrane depolarization to -10 mV was abolished by TeTx (6% of control) but only moderately inhibited by BoNT/A (30% of control). Depolarization to 0 mV to maximize Ca(2+) influx partially overcame BoNT/A (50% of control) but not TeTx inhibition. Of note, cAMP activation potentiated Ca(2+)-evoked secretion by 129% in control cells but only 55% in BoNT/A-transfected cells and had negligible effects in TeTx-transfected cells. These results indicate that, whereas VAMP-2 is absolutely necessary for insulin exocytosis, the effects of SNAP-25 depletion on exocytosis, perhaps on insulin granule pool priming or mobilization steps, could be partially reversed by higher levels of Ca(2+) or cAMP potentiation.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Botulinum Toxins, Type A / pharmacology*
  • Calcium / metabolism*
  • Cell Line
  • Cell Membrane Permeability
  • Clone Cells
  • Cyclic AMP / metabolism*
  • Exocytosis / drug effects
  • Exocytosis / physiology*
  • Glucose / pharmacology
  • Insulin / metabolism*
  • Insulin Secretion
  • Insulinoma
  • Islets of Langerhans / drug effects
  • Islets of Langerhans / metabolism
  • Islets of Langerhans / physiology*
  • Kinetics
  • Membrane Potentials / drug effects
  • Membrane Potentials / physiology*
  • Membrane Proteins / genetics
  • Membrane Proteins / physiology*
  • Nerve Tissue Proteins / genetics
  • Nerve Tissue Proteins / physiology*
  • Pancreatic Neoplasms
  • Patch-Clamp Techniques
  • R-SNARE Proteins
  • Recombinant Proteins / metabolism
  • Synaptosomal-Associated Protein 25
  • Tetanus Toxin / pharmacology*
  • Transfection
  • Tumor Cells, Cultured

Substances

  • Insulin
  • Membrane Proteins
  • Nerve Tissue Proteins
  • R-SNARE Proteins
  • Recombinant Proteins
  • Synaptosomal-Associated Protein 25
  • Tetanus Toxin
  • Cyclic AMP
  • Botulinum Toxins, Type A
  • Glucose
  • Calcium